The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.

Day

January 23, 2021

KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE* 4 carriers

January 23, 2021
Off
Belloy, M. E., Eger, S. J., Le Guen, Y., Napolioni, V., Deters, K. D., Yang, H. S., … & Alzheimer’s Disease Neuroimaging Initiative. Neurobiol Aging. 2021 May; 101: 123–129.
READ MORE

A4 Study Organizers

The A4 Study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute, with study sites in multiple locations.

Quick Search

Share the A4 Study

©2019 A4 Study

Your upload was successful!